Preoperative administration of controlled-release oxycodone vs morphine as transition oppioid for TIVA in pain control post VATS - ND
- Conditions
- Patients subjects at VATS for spontaneus pneumothoraxMedDRA version: 9.1Level: LLTClassification code 10062043Term: Lung operation
- Registration Number
- EUCTR2008-002662-56-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA DI PARMA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
·Patients scheduled for Video-assisted thoracoscopic surgery for spontaneous pneumothorax
·Age between 18 and 65 years
·ASA status I-II
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
·ASA status ≥ III
·Documented myocardial infarction in the previous 6 months
·Renal insufficiency (creatinine > 2mg/dl)
·Uncontrolled hypertension
·BMI>30
·Psychiatric disorders
·Actual or suspected pregnancy
·Allergy to NSAIDs or to other protocol drugs
·Anaemia
·Epilepsy
·Family history or previous history of malignant hyperthermia
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Difference in total morphine consumption at 48 hours between groups.;Secondary Objective: Difference in length of stay in recovery room between groups.<br>Difference in Visual Analogue Scale Scores recorded 1 hour after the end of surgery between groups.;Primary end point(s): Difference in total morphine consumption at 48 hours between groups.
- Secondary Outcome Measures
Name Time Method